Lupin's Strategic Semaglutide Partnership with Galenicum Health
Published on: Jan. 21, 2026, 11:51 a.m. | Source: Devdiscourse
Lupin's subsidiary, Lupin Atlantis Holdings SA, has partnered with Galenicum Health to develop and distribute Semaglutide, a diabetes and weight management medication. Galenicum will handle development, manufacturing, and supply while Lupin manages regulatory approvals and distribution across 23 countries, enhancing access to the treatment globally.
